Nantahala discloses 9.99% BiomX Inc. (PHGE) ownership with 156,696 shares
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
BiomX Inc. (PHGE) received an updated ownership report from Nantahala Capital Management and its principals, Wilmot B. Harkey and Daniel Mack. As of December 31, 2025, they may be deemed to beneficially own 156,696 shares of common stock, or 9.99% of the outstanding class.
This total includes 41,901 shares that can be acquired within sixty days through warrant exercises. The reporting persons have no sole voting or dispositive power, but share voting and dispositive power over all 156,696 shares. A Nantahala-advised fund, BLACKWELL PARTNERS LLC - SERIES A, has rights to dividends and sale proceeds on more than five percent of the outstanding shares reported.
Positive
- None.
Negative
- None.
FAQ
What ownership stake in BiomX Inc. (PHGE) is reported in this Schedule 13G/A?
The filing reports that Nantahala Capital Management and its principals may beneficially own 156,696 shares of BiomX Inc., representing 9.99% of the common stock outstanding as of December 31, 2025, including shares issuable upon exercise of warrants.
Who are the reporting persons in the BiomX Inc. (PHGE) Schedule 13G/A?
The reporting persons are Nantahala Capital Management, LLC, and its managing members, Wilmot B. Harkey and Daniel Mack. They report shared voting and investment power over 156,696 BiomX Inc. shares held by funds and separately managed accounts under Nantahala’s control.
What role does BLACKWELL PARTNERS LLC - SERIES A play in BiomX Inc. (PHGE) ownership?
BLACKWELL PARTNERS LLC - SERIES A, a fund advised by Nantahala, has the right to receive or direct dividends and sale proceeds from more than five percent of BiomX’s outstanding common stock beneficially owned by Nantahala, as disclosed in the ownership statement.
What does the certification in the BiomX Inc. (PHGE) Schedule 13G/A state about control intentions?
The certification states the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of BiomX Inc., and not in connection with transactions having that purpose, other than activities solely related to a nomination under Rule 240.14a-11.